The genes CDKN2A, CDKN2B, and RB1 function as tumor suppressors; their decreased expression occurs via several mechanisms, including methylation, and contributes to the development of neoplasias [29, 45–52]. This evidence concerns the gene CDKN2B and neoplasm.